Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Chemical Abortion

Chemical Abortion

74 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
74 results
featured-image
Chemical Abortion

A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015

Existing research on postabortion emergency room visits is sparse and limited by methods which underestimate the incidence of adverse events following abortion. Postabortion emergency room (ER) use since Food and Drug Administration approval of chemical abortion in 2000 can identify trends in the relative morbidity burden of chemical versus surgical procedures.

featured-image
Chemical Abortion

Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019

Objectives: Primary: Analyze the Adverse Events (AEs) reported to the Food and Drug Administration (FDA) after use of mifepristone as an abortifacient. Secondary: Analyze maternal intent after ongoing pregnancy and investigate hemorrhage after mifepristone alone.

featured-image
Chemical Abortion

Health Risk: Alaska DHSS Data Reveals Dramatic Increase in Risky Abortion Method

The most recent Alaska Department of Health and Social Services abortion data shows a dramatic increase in the number of women using potentially dangerous abortion drugs, which according to multiple peer-reviewed studies pose higher rates of complications.

Chemical Abortion

Abortion Pill Reversal: A Record of Safety and Efficacy

Chemical abortions have been increasing over recent years to now account for 44 percent of reported abortions in the United States in 2019.[1] These percentages have grown consistently from 6% in 2001 and will likely rise even faster as abortion providers pressure the Food and Drug Administration (FDA) and lawmakers to allow them to sell chemical abortions to women online, without a single, in-person visit to a doctor to verify the gestational age or location of the baby.

featured-image
Chemical Abortion

Health Risk: State of Florida Data Reveals Dramatic Increase in Risky Abortion Method

Newly released State of Florida abortion data shows a dramatic increase in the number of women using potentially dangerous abortion drugs, which according to multiple peer-reviewed studies pose higher rates of complications.

featured-image
Chemical Abortion

Health Risk: Wisconsin Department of Health Services Data Reveals Sharp Increase in Risky Abortion Method

The most recent Wisconsin abortion data shows a significant increase in the number of women using potentially dangerous abortion drugs, which according to multiple peer-reviewed studies pose higher rates of complications.

featured-image
Chemical Abortion

Health Risk: Nebraska’s 2020 Abortion Report Reveals Sharp Increase in Chemical Abortions

Newly released Nebraska abortion data shows a significant increase in women using potentially dangerous abortion drugs, which have been found to pose higher rates of complications.

featured-image
Chemical Abortion

The Impact of Chemical Abortion by Mail

Due to the COVID-19 pandemic, the U.S. abortion industry has undergone significant changes. The Food and Drug Administration (FDA) regulates mifepristone, the more dangerous first drug of the two-part chemical abortion cocktail, via a Risk Evaluation and Mitigation Strategy (REMS), which limits how the drug can be dispensed. After years of fighting these safety standards, the abortion industry took advantage of the pandemic to obtain a court order in July 2020 blocking the requirement that mifepristone be administered in person, a key element of the REMS.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image